Maitreya Medicare (NSE:MAITREYA) Other Current Receivables: ₹23.43 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MAITREYA Maitreya Medicare Ltd NSE:MAITREYA
26 GF Score
Price ₹116.00
GF Value ₹459.99
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Maitreya Medicare Other Current Receivables?

Maitreya Medicare NSE:MAITREYA -4.13% 26 Other Current Receivables is ₹23.43 Mil as of Mar. 2026. GuruFocus rates NSE:MAITREYA with a GF Score™ of 26/100 and a GF Value™ of ₹459.99 (Possible Value Trap). The stock has 7 warning signs investors should review.

Maitreya Medicare's Other Current Receivables for the quarter that ended in Mar. 2026 was ₹23.43 Mil.

Maitreya Medicare's quarterly Other Current Receivables increased from Mar. 2025 (₹0.00 Mil) to Sep. 2025 (₹27.30 Mil) but then stayed the same from Sep. 2025 (₹27.30 Mil) to Mar. 2026 (₹23.43 Mil).

Maitreya Medicare's annual Other Current Receivables declined from Mar. 2023 (₹0.16 Mil) to Mar. 2025 (₹0.00 Mil) but then increased from Mar. 2025 (₹0.00 Mil) to Mar. 2026 (₹23.43 Mil).

Maitreya Medicare Other Current Receivables Related Terms

Maitreya Medicare Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Maitreya Medicare's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maitreya Medicare Other Current Receivables Chart

Maitreya Medicare Annual Data
Trend Mar21 Mar22 Mar23 Mar25 Mar26
Other Current Receivables
0.00 0.13 0.16 0.00 23.43

Maitreya Medicare Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Sep24 Mar25 Sep25 Mar26
Other Current Receivables Get a 7-Day Free Trial 0.26 0.00 0.00 27.30 23.43
NSE:MAITREYA
26GF Score
Maitreya Medicare Ltd NSE:MAITREYA
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maitreya Medicare Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹23.43 Mil mean?
Maitreya Medicare (NSE:MAITREYA) has a Other Current Receivables of ₹23.43 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Maitreya Medicare and its competitors.
Is Maitreya Medicare's Other Current Receivables too high?
Maitreya Medicare's current Other Current Receivables is ₹23.43 Mil. Overall, Maitreya Medicare has a GF Score™ of 26/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's Other Current Receivables compare to HCA and DVA?
Maitreya Medicare's Other Current Receivables of ₹23.43 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Maitreya Medicare and its competitors. Maitreya Medicare's current Other Current Receivables is ₹23.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Based on GuruFocus' analysis, Maitreya Medicare (NSE:MAITREYA) is currently considered Possible Value Trap. The stock's GF Value™ is ₹459.99, compared to a current price of ₹116.00 — trading 74.8% below its estimated fair value. The current Other Current Receivables is ₹23.43 Mil. Maitreya Medicare's overall GF Score™ is 26/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current Other Current Receivables is ₹23.43 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maitreya Medicare (NSE:MAITREYA) Overvalued in 2026?

Based on GuruFocus' analysis, Maitreya Medicare stock appears to be undervalued. The current stock price of ₹116.00 is trading 74.8% below its estimated GF Value™ of ₹459.99. GuruFocus considers Maitreya Medicare to be Possible Value Trap.

Key valuation signals for NSE:MAITREYA:

  • Other Current Receivables: ₹23.43 Mil
  • GF Value™: ₹459.99 vs. price of ₹116.00 (74.8% below fair value)
  • GF Score™: 26/100 with 7 warning signs

No single metric tells the full story. See the NSE:MAITREYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Maitreya Medicare Business Description

Address Nr. Someshwara Char Rasta, Udhana - Magdalla Road, Surat, GJ, IND, 395007
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
26GF Score

Get the complete analysis for NSE:MAITREYA

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹116.00
Price
₹459.99
GF Value